Spots Global Cancer Trial Database for treatment naive
Every month we try and update this database with for treatment naive cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Anti-Tumor Activity Of SB-485232 In Patients With Previously Untreated Metastatic Melanoma | NCT00107718 | Melanoma | SB-485232 | 18 Years - | GlaxoSmithKline | |
| A Study of Fully Human BCMA CAR-T (CT103A) in Patients With Newly Diagnosed High-risk Multiple Myeloma (FUMANBA-2) | NCT05181501 | Multiple Myelom... | Fully human BCM... | 18 Years - 70 Years | Nanjing IASO Biotechnology Co., Ltd. | |
| Tolerability, Safety, & Efficacy of Argon Plasma Coagulation to Treat Anal Intraepithelial Neoplasia in HIV-Positive Men | NCT00428285 | Anus Neoplasms HIV Infections | Argon Plasma Co... | 18 Years - 65 Years | Centre hospitalier de l'Université de Montréal (CHUM) | |
| Anti-Tumor Activity Of SB-485232 In Patients With Previously Untreated Metastatic Melanoma | NCT00107718 | Melanoma | SB-485232 | 18 Years - | GlaxoSmithKline | |
| A Study of BIIB022 in Combination With Paclitaxel and Carboplatin in Subjects With Non-Small Cell Lung Cancer | NCT00970580 | Non-Small Cell ... | BIIB022 With Pa... | 18 Years - | Biogen | |
| Oral Human Papillomavirus Infection in HIV-infected Men | NCT00421486 | Papillomavirus ... HIV Infections | Oral swabs for ... | 18 Years - | Deutsche Luft und Raumfahrt | |
| A Study of BR Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated MCL | NCT02972840 | Lymphoma, Mantl... | Acalabrutinib Bendamustine Rituximab Placebo | 65 Years - | Acerta Pharma BV | |
| Study of IMO-2055 in Metastatic or Locally Recurrent Clear Cell Renal Carcinoma | NCT00729053 | Renal Cell Carc... | IMO-2055 | 18 Years - | Idera Pharmaceuticals, Inc. | |
| Oral Human Papillomavirus Infection in HIV-infected Men | NCT00421486 | Papillomavirus ... HIV Infections | Oral swabs for ... | 18 Years - | Deutsche Luft und Raumfahrt | |
| The Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in HIV-Infected Women | NCT00006444 | HIV Infections Papilloma | 13 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | ||
| A Study of Dabrafenib in Combination With Trametinib in Chinese Patients With BRAF V600E Mutant Metastatic NSCLC | NCT04452877 | Carcinoma, Non-... | Dabrafenib Trametinib | 18 Years - | Novartis | |
| The Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in HIV-Infected Women | NCT00006444 | HIV Infections Papilloma | 13 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | ||
| Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC) | NCT02903160 | Prostate Cancer | Abiraterone ace... Prednisone Radium-223 dich... cabazitaxel Carboplatin Enzalutamide | 18 Years - | Icahn School of Medicine at Mount Sinai | |
| Acalabrutinib-Lenalidomide-Rituximab in Patients With Untreated MCL | NCT03863184 | Mantle Cell Lym... | Acalabrutinib Lenalidomide Rituximab | 18 Years - | Weill Medical College of Cornell University | |
| Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma | NCT02911142 | Primary Effusio... B-Cell Neoplasm | Lenalidomide Rituximab Prednisone Etopside Doxorubicin Vincristine Cyclophosphamid... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| A Study of BR Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated MCL | NCT02972840 | Lymphoma, Mantl... | Acalabrutinib Bendamustine Rituximab Placebo | 65 Years - | Acerta Pharma BV | |
| A Study of BIIB022 in Combination With Paclitaxel and Carboplatin in Subjects With Non-Small Cell Lung Cancer | NCT00970580 | Non-Small Cell ... | BIIB022 With Pa... | 18 Years - | Biogen | |
| A Study of BR Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated MCL | NCT02972840 | Lymphoma, Mantl... | Acalabrutinib Bendamustine Rituximab Placebo | 65 Years - | Acerta Pharma BV | |
| A Study of Fully Human BCMA CAR-T (CT103A) in Patients With Newly Diagnosed High-risk Multiple Myeloma (FUMANBA-2) | NCT05181501 | Multiple Myelom... | Fully human BCM... | 18 Years - 70 Years | Nanjing IASO Biotechnology Co., Ltd. | |
| Inflammatory Cytokines in Symptom Production in Multiple Myeloma | NCT00688168 | Multiple Myelom... | Questionnaire Neurocognitive ... Neurosensory Te... | 18 Years - | M.D. Anderson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
